Throughout life, your breasts naturally undergo various changes. However, distinguishing between benign (non-cancerous) and ...

In a 2017 study published in the Asian Journal of Pharmaceutical and Clinical Research, data showed that female rats treated ...

Once the team made MuMuTAs work, they used five of them to actuate multi-jointed fingers in a robotic hand.

Children with rheumatic diseases may face increased risks for COVID-19-related hospitalization, particularly those using glucocorticoids, rituximab, or mycophenolate.

Treatment with deucravacitinib in patients with active PsA showed higher response rates and improvement in quality of life ...

For example, researchers at Thomas Jefferson University in Philadelphia found that people with xylazine-associated wounds are often denied admittance to detox and rehabilitation programs until their ...

Panelists discuss how combining systemic therapy with locoregional treatments like transarterial chemoembolization (TACE) aims to enhance therapeutic efficacy by addressing its limitations, such as ...

Acute kidney injury (AKI) is estimated to occur in up to 50% of patients with liver cirrhosis and is associated with increased morbidity and a high risk of short-term and long-term mortality.1 ...

Compared with controls, patients with IC/BPS with different BWT had significantly higher urinary levels of tumor necrosis ...

In patients with ulcerative colitis, vedolizumab outperformed infliximab as a second-line therapy following failure of ...

Fat necrosis refers to dead or damaged breast tissue that often manifests as a noncancerous lump under the skin. In most cases, these lumps go away on their own and don’t return. Fat necrosis of ...